Crossref
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan (lay summary)
AfricArXiv · 03.07.2023
DOI: 10.21428/3b2160cd.432e820e ↗Kurz gefasst
Fachartikel in der Zeitschrift AfricArXiv, online erschienen am 03.07.2023. Verfasst von ScienceLink.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
ScienceLink (2023). Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan (lay summary). AfricArXiv. https://doi.org/10.21428/3b2160cd.432e820e
Vancouver
ScienceLink. Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan (lay summary). AfricArXiv. 2023. doi:10.21428/3b2160cd.432e820e
BibTeX
@article{ScienceLink2023,
author = {ScienceLink},
title = {Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan (lay summary)},
journal = {AfricArXiv},
year = {2023},
doi = {10.21428/3b2160cd.432e820e}
}
EUVIMED